Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Immunome, Inc. in Washington state is seeking a Bioanalyst to develop and implement bioanalytical assays supporting clinical-stage bioanalysis for oncology programs. You will design, develop, and execute bioanalytical strategies across multiple candidates under supervision.
Key responsibilities include overseeing CROs, collaborating across functions, and authoring study protocols, analysis plans, and regulatory submissions to advance programs through development.
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.
The Bioanalyst will be responsible for developing and implementing bioanalytical assays to support clinical stage bioanalysis for candidate drugs. In this role, they will participate in the design, development, and implementation of the bioanalytical strategy for multiple oncology programs. This role reports to the Associate Director, Bioanalytical.
Washington State Pay Range
$120,200 - $141,960 USD
Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.